Key points- An authorization is needed for uses HIPAA does not otherwise permit. Routine treatment, payment and health care operations do not need one.
- The rule sets six core elements and three required statements. A form that leaves one out is defective.
- A consent to treat, or an optional HIPAA consent, is not an authorization and cannot stand in for one.
- Research authorizations may use "end of the research study" or "none" as the expiration and may be combined with research consent.
- Keep each signed authorization for six years from when it was signed or last in effect, whichever is later.
A HIPAA consent form is optional; an authorization is required where the rule demands one. Under the regulation, "A covered entity may obtain consent of the individual to use or disclose protected health information to carry out treatment, payment, or health care operations" (45 CFR 164.506). HHS adds that the rule "permits, but does not require" that consent, and that "Where the Privacy Rule requires patient authorization, voluntary consent is not sufficient to permit a use or disclosure of protected health information unless it also satisfies the requirements of a valid authorization" (HHS).
Patients often sign several papers at intake, and only some of them are HIPAA documents. The table separates them.
| Document | What it does | Required? |
|---|
| Consent to treatment | Agrees to examination and care | Set by state law: HIPAA "does not affect informed consent for treatment, which is addressed by State law" (HHS) |
| HIPAA consent form | Agrees to routine uses of PHI for treatment, payment and operations | Optional under 45 CFR 164.506(b) |
| HIPAA authorization form | Permits a specific use or disclosure HIPAA does not otherwise allow | Required for that use or disclosure under 45 CFR 164.508 |
| Research informed consent | Agrees to take part in a research study | Required for most research the Common Rule covers (45 CFR 46.116) |
The second row cannot do the third row's job. The rule says consent "shall not be effective to permit a use or disclosure of protected health information when an authorization" is required (45 CFR 164.506).
The requirements are in 45 CFR 164.508(c). "A valid authorization under this section must contain at least the following elements", and then three statements that put the patient on notice (45 CFR 164.508). The table lists each one with the rule's own words.
| Required part | What the rule says | In practice |
|---|
| 1. The information | "A description of the information to be used or disclosed that identifies the information in a specific and meaningful fashion." | Name the record types and dates, such as visit notes and lab results for a set period |
| 2. Who may disclose | The person or "class of persons, authorized to make the requested use or disclosure" | The practice, or a named department |
| 3. Who may receive | The person or "class of persons, to whom the covered entity may make the requested use or disclosure" | A named insurer, attorney or study team |
| 4. Purpose | "A description of each purpose of the requested use or disclosure." | When the patient starts the request, "at the request of the individual" is enough |
| 5. Expiration | "An expiration date or an expiration event that relates to the individual or the purpose of the use or disclosure." | A date, or an event such as the end of a claim |
| 6. Signature and date | "Signature of the individual and date." | A personal representative must show their authority |
| Statement: revocation | "The individual's right to revoke the authorization in writing" | Say how to revoke and the exceptions |
| Statement: conditioning | "The ability or inability to condition treatment, payment, enrollment or eligibility for benefits on the authorization" | Usually: care does not depend on signing |
| Statement: redisclosure | The information may be redisclosed by the recipient "and no longer be protected by this subpart" | Tell the patient HIPAA may not follow the records |
Three more rules apply to the whole form. "The authorization must be written in plain language." The practice "must provide the individual with a copy of the signed authorization". And a form "may contain elements or information in addition to the elements required by this section", as long as they are "not inconsistent" with them (45 CFR 164.508).
Whenever a use or disclosure is not permitted some other way. Three cases always need one, whatever else applies:
- Psychotherapy notes. "A covered entity must obtain an authorization for any use or disclosure of psychotherapy notes", with narrow exceptions such as "Use by the originator of the psychotherapy notes for treatment" (45 CFR 164.508). These are a mental health professional's notes "documenting or analyzing the contents of conversation during a private counseling session", kept apart from the rest of the record (45 CFR 164.501). See psychotherapy notes.
- Marketing. "A covered entity must obtain an authorization for any use or disclosure of protected health information for marketing", except "A face-to-face communication made by a covered entity to an individual" and "A promotional gift of nominal value provided by the covered entity."
- A sale of PHI, covered further down this page.
The rule also limits pressure to sign: "A covered entity may not condition the provision to an individual of treatment, payment, enrollment in the health plan, or eligibility for benefits on the provision of an authorization", with a few exceptions such as research-related treatment (45 CFR 164.508). Most other requests from outside parties that are not care, payment or a listed legal exception, such as a life insurer's underwriting request, also need a signed form. This page is general information, not legal advice.
The same core elements, with three differences. First, the expiration can be open: "The statement "end of the research study," "none," or similar language is sufficient if the authorization is for a use or disclosure of protected health information for research, including for the creation and maintenance of a research database or research repository" (45 CFR 164.508).
Second, research forms may be combined. Other authorizations "may not be combined with any other document to create a compound authorization", but a research authorization "may be combined with any other type of written permission for the same or another research study", including "a consent to participate in research". Third, "A covered health care provider may condition the provision of research-related treatment on provision of an authorization" for that research (45 CFR 164.508).
Research can also proceed without individual forms. A covered entity may use or disclose PHI for research when it "obtains documentation that an alteration to or waiver, in whole or in part, of the individual authorization required by" the rule was approved by an IRB or a privacy board (45 CFR 164.512). Where federal human subjects rules also apply, HHS says "Where both the Privacy Rule and the Common Rule apply, both regulations must be followed" (HHS).
A research authorization signed with a trial consent form still needs reading for AI use: see clinical trial data on participants' consent, and genomic data on NIH's sharing terms.
In two cases. For marketing that a third party pays for, "the authorization must state that such remuneration is involved". For a sale of PHI, "a covered entity must obtain an authorization for any disclosure of protected health information which is a sale of protected health information", and "Such authorization must state that the disclosure will result in remuneration to the covered entity" (45 CFR 164.508(a)(4)).
A sale is a disclosure where the practice "directly or indirectly receives remuneration from or on behalf of the recipient of the protected health information in exchange for the protected health information" (45 CFR 164.502). Some disclosures are carved out, including research where the only payment is "a reasonable cost-based fee to cover the cost to prepare and transmit the protected health information for such purposes", and the sale or merger of the practice itself.
So a general release that a patient signed for a records request does not cover a paid disclosure, and neither does a research authorization that never mentions payment. De-identified data sits outside these rules: "The requirements of this subpart do not apply to information that has been de-identified in accordance with the applicable requirements of" the de-identification standard (45 CFR 164.502). See HIPAA de-identification and who owns patient records.
Yes. "An individual may revoke an authorization provided under this section at any time, provided that the revocation is in writing", except where "The covered entity has taken action in reliance thereon" (45 CFR 164.508). Records already sent stay sent; nothing new goes out after the revocation arrives.
"A covered entity must document and retain any signed authorization", and the retention rule is six years: documentation is kept "for six years from the date of its creation or the date when it last was in effect, whichever is later" (45 CFR 164.530). A research authorization that says "none" stays in effect until revoked, so its six years start only then. For how long the medical record itself is kept, see patient record retention by state.
Track revocations and expiry dates in one place. An authorization is defective once "The expiration date has passed or the expiration event is known by the covered entity to have occurred", or when it "is known by the covered entity to have been revoked".
Most defective authorizations fail for one of these reasons. The rule's own list of defects includes a form that "has not been filled out completely" and one where "Any material information in the authorization is known by the covered entity to be false" (45 CFR 164.508).
- Treating an intake consent or a notice acknowledgment as if it were an authorization.
- Writing "all records" when the purpose needs only part of the chart.
- Leaving the expiration or the recipient blank.
- Folding psychotherapy notes into a general release instead of a separate form.
- Combining an authorization with an unrelated document, which the compound rule forbids outside research.
- Making care depend on signing when no exception applies.
- Leaving out the payment statement for paid marketing or a sale of PHI.
- Not giving the patient a copy, or not keeping the signed form for six years.
Yes. Few practices ever ask patients for an authorization that names payment and an outside recipient, so most archives can be used outside the practice only once they are de-identified or covered by research rules. AI data buyers have asked Origin for longitudinal EHR records (patient records over time with diagnoses, medications, labs and outcomes), imaging with reports (CT, MRI, X-ray and pathology slides), behavioral health and specialty care records, and doctor-patient conversation audio with transcripts, which is the newest request.
The buyers have also said what these deals need to get through: de-identification signed off by an independent third party under HIPAA's Expert Determination method, not by the seller; IRB approval, or patient consent that covers commercial licensing; and a clear chain of rights showing who collected the data, who owns it and who can license it. A signed authorization or research consent whose purposes and recipients cover commercial licensing is one way to meet the second requirement; a general records release is not. What must come out first: names and the other identifiers, with an independent expert's sign-off on the result; psychotherapy notes; records of patients who revoked or refused; and anything the practice does not hold the rights to, such as data an EHR vendor's contract reserves. See what a health data license requires.
Origin is an independent data partner. It does not perform Expert Determination or IRB review. It helps a practice work out what records it holds, which of these three requirements it already meets and what is missing. The practice decides what is shared and signs any license itself, and a buyer may pay Origin when a deal closes.
Does your company hold records like these? See what your data is worth.
Common questions
What is the difference between a HIPAA authorization form and a HIPAA consent form?
A HIPAA consent form is optional and covers routine uses of health information for treatment, payment and health care operations. A HIPAA authorization form is required for uses HIPAA does not otherwise allow, such as marketing, psychotherapy notes or a sale of records. HHS says voluntary consent is not enough where an authorization is required unless it meets every authorization requirement.
Does a HIPAA authorization form need an expiration date?
Yes. Under 45 CFR 164.508(c)(1)(v) it needs an expiration date or an expiration event tied to the patient or the purpose, such as the end of a claim. Research authorizations are the exception: "end of the research study" or "none" is enough, including for a research database. A form whose date has passed or whose event has occurred is no longer valid.
Who can sign a HIPAA authorization for someone else?
A personal representative: someone who, under state law, has authority to make health care decisions for the patient, such as a parent or guardian of a minor in most cases. HIPAA treats that person as the patient. The form must then describe the representative's authority to act, as 45 CFR 164.508(c)(1)(vi) requires. Keep a copy of that authority with the form.
What makes a HIPAA authorization form invalid?
The rule lists five defects: the expiration date has passed or the expiration event has occurred; a required element is not filled out; the practice knows it was revoked; it breaks the rules on combining forms or conditioning care on signing; or the practice knows material information in it is false. A form missing a required statement is also not valid.
How long should a practice keep signed HIPAA authorizations?
Six years from the date the authorization was created or the date it was last in effect, whichever is later, under 45 CFR 164.530(j). A form that never expires, such as a research authorization marked "none", stays in effect until it is revoked, so the six years run from the revocation. State law may ask for longer.
Does a HIPAA authorization have to say the practice is being paid?
Only in two cases. If a third party pays for a marketing communication, the authorization must say remuneration is involved. If the disclosure is a sale of protected health information, the authorization must state that the disclosure will result in remuneration to the covered entity. A general release that never mentions payment does not cover either case.
Can a practice refuse to treat a patient who will not sign a HIPAA authorization?
Generally no. A covered entity may not condition treatment, payment, enrollment or eligibility for benefits on signing an authorization. The main exceptions are research-related treatment, which may depend on a research authorization, and care given only to create information for a third party, such as an exam an employer requests. The form itself must state which rule applies.
Sources and further reading